TAO Synergies TAOX
NASDAQ TAOX
$4.53 +0.21 (+4.86%)
At close: Sep 30, 2026 · 4:00 PM EDT

TAO Synergies (TAOX) Capital Expenditures (2020 - 2023)

Updated

TAO Synergies' Capital Expenditures was $2,707 in FY2023, down 63.5% from $7,414 in FY2022.

Analysis

TAO Synergies (TAOX) Capital Expenditures (2020 - 2023) Analysis & Trends

From FY2019 onward, TAO Synergies has reported Capital Expenditures for 5 years.

  • Capital Expenditures shows a four-year compound annual growth rate of -15.1% (FY2019 to FY2023).
  • The FY2023 figure marks the lowest annual Capital Expenditures in data going back to FY2019.
  • Per Business Quant data, Capital Expenditures in earlier years was $7,414 in FY2022 (+131.8%), $3,199 in FY2021 (-40.9%), $5,413 in FY2020 (+3.8%) and $5,214 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 TAO Synergies 33.85 Mn 33.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 669.00
Mar 31, 2023 2,038.00
Dec 31, 2022 2,139.00
Sep 30, 2022 2,246.00
Jun 30, 2020 2,814.00
Mar 31, 2020 2,599.00
API Access

TAO Synergies Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TAOX&period=max&api_key=YOUR_API_KEY